Tuesday, February 19, 2019
Home Tags Novavax

Tag: Novavax

Tread Carefully When It Comes To Novavax, Inc. (NVAX)

Despite closing 0 points lower on 14 February, Novavax, Inc. (NASDAQ:NVAX) remains a key investment for many, but the stock is also a popular...

Novavax, Inc. (NVAX) Alerting Bullish Trading Activity

Considering all key technical indicators, a 40% Buy signal has occurred for Novavax, Inc. (NASDAQ:NVAX). The stock is also flashing a Buy from the...

Analysts Flashing a Green Light for Novavax, Inc. (NVAX)?

Analysts at Ladenburg Thalmann, assumed coverage of Novavax, Inc. (NASDAQ:NVAX) with Buy recommendation, according to their opinion released on December 18. Analysts at Piper...

Novavax, Inc. (NVAX) Trading Notes: Monitoring Upcoming Technical Tailwinds

Considering all key technical indicators, a 72% Buy signal has occurred for Novavax, Inc. (NASDAQ:NVAX). The stock is also flashing a Buy from the...

Is Novavax, Inc. (NVAX) Becoming More Panic-Prone?

Undoubtedly, Novavax, Inc. (NASDAQ:NVAX) has been one of the most volatile stocks in the market in recent times, and the way it handled Wednesday's...

Novavax, Inc. (NVAX): 1 Aspect That’s Somewhat Worrisome

Short sellers are betting against Novavax, Inc. (NASDAQ:NVAX). Looking at the sentiment indicator for the NVAX stock we see that the short-interest ratio is...

Novavax, Inc. (NVAX): A Good Time To Get In The Game?

Analysts at Ladenburg Thalmann, assumed coverage of Novavax, Inc. (NASDAQ:NVAX) with Buy recommendation, according to their opinion released on December 18. Analysts at Piper...

Novavax, Inc. (NVAX): The Insiders Are Selling, Are You?

With 0 sell/buy ratio, Novavax, Inc. (NASDAQ:NVAX) experienced more insider buying than insider selling over the last twelve months. Could this be a sign...

Novavax, Inc. (NVAX) Ready To Tore A Hole Through The Roof

After opening Thursday at around $2.29, Novavax, Inc. (NASDAQ:NVAX) stock surged to as high as $2.44. It then made a downturn, dipping as low...

Novavax, Inc. (NVAX) Could Be A Humongous Winner

Analysts at Ladenburg Thalmann, assumed coverage of Novavax, Inc. (NASDAQ:NVAX) with Buy recommendation, according to their opinion released on December 18. Analysts at Piper...

MOST POPULAR